Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$58,685,970
+$780,128 QoQ
Shares Held
233,214
-12.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#337
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$22,508
PutShares
15,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $233,466,304 across 14 Drug Manufacturers - General names. ABBV ranks #2 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
277,688 | $70,524,421 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
233,214 | $58,685,970 | |
| 3 | MRK |
Merck & Co., Inc.
|
266,566 | $34,253,731 | |
| 4 | AMGN |
Amgen Inc
|
55,311 | $20,029,219 | |
| 5 | PFE |
Pfizer Inc
|
744,034 | $17,916,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
194,227 | $11,191,359 | |
| 7 | AZN |
Astrazeneca PLC
|
30,398 | $5,764,068 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
43,759 | $5,528,512 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,685,970 | 233,214 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $57,905,842 | 266,246 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $64,912,638 | 284,094 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $63,993,719 | 276,383 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $51,961,720 | 279,936 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $56,338,670 | 268,894 | Shares | Other | 2025-05-05 | |
| 2024-12-31 | $84,822,784 | 477,337 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $54,535,879 | 276,159 | Shares | Other | 2024-10-22 | |
| 2024-06-30 | $48,120,107 | 280,551 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $46,554,775 | 255,655 | Shares | Other | 2024-04-30 | |
| 2023-12-31 | $40,494,280 | 261,304 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,508 | 15,100 | Put | Sole | 2023-11-03 | |
| 2023-09-30 | $38,963,836 | 261,397 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $36,110,334 | 268,020 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $43,764,595 | 274,610 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $47,889,891 | 296,330 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $41,300,980 | 307,734 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $59,671,901 | 389,605 | Shares | Sole | 2022-07-13 | |
| 2021-12-31 | $54,618,870 | 403,389 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $60,029,870 | 556,502 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $44,401,336 | 394,188 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $39,201,504 | 362,239 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $30,176,975 | 281,633 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $19,663,166 | 224,491 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $22,009,010 | 224,170 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $14,831,678 | 194,667 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||